当前位置：
X-MOL 学术
›
J. Asthma Allergy
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Profile of Anti-IL-5 mAb Mepolizumab in the Treatment of Severe Refractory Asthma and Hypereosinophilic Diseases [Corrigendum]
Journal of Asthma and Allergy ( IF 3.2 ) Pub Date : 2021-06-29 , DOI: 10.2147/jaa.s326321 Francesco Menzella , Mirco Lusuardi , Carla Galeone , Sofia Taddei , Luigi Zucchi
Journal of Asthma and Allergy ( IF 3.2 ) Pub Date : 2021-06-29 , DOI: 10.2147/jaa.s326321 Francesco Menzella , Mirco Lusuardi , Carla Galeone , Sofia Taddei , Luigi Zucchi
Corrigendum for the article Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
中文翻译：
抗 IL-5 mAb 美泊利单抗治疗重度难治性哮喘和高嗜酸性粒细胞疾病的概况 [勘误]
抗 IL-5 mAb 美泊利单抗治疗重度难治性哮喘和高嗜酸性粒细胞疾病的文章简介
更新日期：2021-06-29
中文翻译：
抗 IL-5 mAb 美泊利单抗治疗重度难治性哮喘和高嗜酸性粒细胞疾病的概况 [勘误]
抗 IL-5 mAb 美泊利单抗治疗重度难治性哮喘和高嗜酸性粒细胞疾病的文章简介
京公网安备 11010802027423号